A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)

被引：0

作者：

P. M. Clarke

A. M. Gray

A. Briggs

A. J. Farmer

P. Fenn

R. J. Stevens

D. R. Matthews

I. M. Stratton

R. R. Holman

机构：

[1] University of Oxford,Health Economics Research Centre, Department of Public Health

[2] University of Oxford,Department of Primary Health Care

[3] University of Nottingham,Business School

[4] Churchill Hospital,Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism

[5] Churchill Hospital,Oxford Centre for Diabetes, Endocrinology and Metabolism

来源：

Diabetologia | 2004年 / 47卷

关键词：

Blood glucose; Diabetes; Diabetes-related complications; Economic evaluation; Life expectancy; Quality-adjusted life years; Risk equation simulation model; UKPDS;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1747 / 1759

页数：12

共 50 条

[31] Validating the UKPDS 82 Risk Equations to Contemporary Outcomes Studies in Type 2 Diabetes
Grant, David M.
Foos, Volker
Mcewan, Philip C.
DIABETES, 2014, 63 : A619 - A619
[32] VALIDATING THE UKPDS 82 RISK EQUATIONS TO CONTEMPORARY OUTCOMES STUDIES IN TYPE 2 DIABETES
Grant, D.
Foos, V
McEwan, P.
VALUE IN HEALTH, 2014, 17 (03) : A252 - A252
[33] VALIDATION OF UKPDS OUTCOMES AND TAIWAN DIABETES MODELS ON TAIWAN TYPE 2 DM POPULATION
Lin, M. Y.
Huang, T. Y.
Liu, J. S.
Hsu, C. C.
Kang, Y.
Hwang, S. J.
Luh, H.
VALUE IN HEALTH, 2020, 23 : S118 - S119
[34] A VALIDATION OF THE UKPDS OUTCOMES MODEL PREDICTIONS IN THE CASALE MONFERRATO SURVEY, AN ITALIAN POPULATION-BASED COHORT OF TYPE 2 DIABETES PATIENTS
Pagano, E.
Bruno, G.
Rosato, R.
Merletti, F.
Gray, A.
EPIDEMIOLOGIA & PREVENZIONE, 2011, 35 (5-6): : 191 - 192
[35] Prediction of mortality and macrovascular complications in type 2 diabetes: validation of the UKPDS Outcomes Model in the Casale Monferrato Survey, Italy
Pagano, E.
Gray, A.
Rosato, R.
Gruden, G.
Perin, P. Cavallo
Merletti, F.
Bruno, G.
DIABETOLOGIA, 2013, 56 (08) : 1726 - 1734
[36] IMPACT OF SINGLE RISK FACTOR CHANGES ON LONG TERM OUTCOMES AND COST IN A TYPE 2 DIABETES MODELING STUDY CONTRASTING PROJECTIONS WITH UKPDS 68 VERSUS UKPDS 82 RISK EQUATIONS
Foos, V
McEwan, P.
Grant, D.
VALUE IN HEALTH, 2014, 17 (07) : A547 - A547
[37] PROGRESSION OF DIABETIC-RETINOPATHY OVER 9 YEARS IN NIDDM PATIENTS IN THE UNITED-KINGDOM PROSPECTIVE DIABETES STUDY (UKPDS)
KOHNER, EM
STRATTON, IM
ALDINGTON, SJ
MATTHEWS, DR
DIABETES, 1995, 44 : A54 - A54
[38] ESTIMATING THE LIFETIME HEALTH OUTCOMES OF TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS INADEQUATELY CONTROLLED ON METFORMIN PLUS SULPHONYLUREA RECEIVING EITHER CANAGLIFLOZIN OR SITAGLIPTIN USING THE UKPDS OUTCOMES MODEL V1.3
Nuhoho, S.
Worbes-Cerezo, M.
VALUE IN HEALTH, 2014, 17 (07) : A558 - A558
[39] External validation of the UK prospective diabetes study (UKPDS) risk engine in patients with type 2 diabetes identified in the national diabetes program in Iran
Valipour, Mehrdad
Khalili, Davood
Solaymani-Dodaran, Masoud
Motevalian, Seyed Abbas
Khamseh, Mohammad Ebrahim
Baradaran, Hamid Reza
JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2023, 22 (02) : 1145 - 1150
[40] Increased Risk of Incident Heart Failure and All-Cause Mortality in Insulin-Resistant People with Type 2 Diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)
Wamil, Malgorzata
Coleman, Ruth L.
Adler, Amanda
Mcmurray, John J.
Holman, Rury R.
DIABETES, 2020, 69

← 1 2 3 4 5 →